This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Sihong Song - Innovator in Gene Therapy
Introduction
Sihong Song is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of gene therapy, focusing on innovative materials and methods that can potentially transform treatment for genetic disorders. His work is particularly relevant in the context of providing therapeutic solutions for conditions that require high levels of specific proteins.
Latest Patents
Sihong Song holds a patent for "Materials and methods for gene therapy." This invention addresses the need for vectors that can effectively deliver genetic therapy in both animals and humans suffering from genetic disorders. The patent outlines methods for treating individuals who require gene therapy to correct or manage their conditions. Notably, the invention can be utilized to treat alpha-1-antitrypsin deficiency, a condition where a critical protein is either absent or non-functional.
Career Highlights
Sihong Song is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research in gene therapy. His work has garnered attention for its potential to improve the quality of life for individuals with genetic disorders.
Collaborations
Sihong has collaborated with notable colleagues such as Terence R Flotte and Barry John Byrne. These partnerships have further enriched his research and contributed to the development of innovative therapeutic approaches.
Conclusion
Sihong Song's contributions to gene therapy exemplify the impact of innovative research on healthcare. His patent and ongoing work at the University of Florida Research Foundation Inc. highlight the importance of developing effective treatments for genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
